Starla J. Sweany, PharmD, BCOP

Most recent by Starla J. Sweany, PharmD, BCOP

SPONSORED CONTENT
October 25, 2011
6 min read
Save

TKIs and the treatment of CML in pregnant women

The use of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia has led to a transformation of chronic myeloid leukemia from a fatal disease without aggressive intervention to a disease that is a chronic condition, with patients having extended life expectancies.